NCT00472901View on ClinicalTrials.gov

Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

September 30, 2010

Conditions
Polymorphic Light Eruption (PLE)
Interventions
DRUG

Afamelanotide (CUV1647)

16mg implant

Trial Locations (3)

Unknown

St Vincents Hospital, Melbourne

Hope Hospital, Manchester

A1090

Medical University of Vienna, Vienna

Sponsors
All Listed Sponsors
lead

Clinuvel Pharmaceuticals Limited

INDUSTRY